CREB3L1 and thyroid cancer: Studies have shown that α-SMA-positive CAFs were activated through CREB3L1-mediated IL-1α production, the presence of CAF inhibits thyroid cancer growth and metastasis after CREB3L1 knockdown (Pan et al., 2022).